Chapter 1133: Future Biomedical Technology

Today, a large number of experts from the global biomedical field have gathered at the headquarters of Future Technology Group.

"In the past, I was rarely involved in medical biotechnology, but among the thousands of laboratories in our group, more than a quarter of the laboratories were dedicated to the research of biomedicine, human health and microbial genes. In four years, thousands of experts and scholars from our group have finally obtained the first research results in this field."

In the face of thousands of experts and scholars from all over the world, as well as countless media reporters, Cai Ruichen showed his youthful and confident appearance, focused on the flashlight, and said seriously and seriously:

"The precision medicine program, Europe, the United States, and a large number of large and developing countries in Asia have all conducted a lot of in-depth research in this field. The reason is simple. Everyone is different in the human body, and all human beings currently use treatments. The medicines for various diseases are all universal, which makes all medicines only suitable for most people. Some people have different constitutions. Even though they are the same medicines, they may not be effective.

This is the reason why various countries have started precision medicine plans. The starting point of future biomedical technology is similar, but there is one difference. Our research field is specifically aimed at the two major medical problems in the world, one is cancer and the other is AIDS.

Take cancer as an example. At present, human medical technology divides cancer into three categories, namely 'small cell carcinoma', 'squamous cell carcinoma' and 'adenocarcinoma'. However, this classification is very helpful for the treatment of cancer. Small.

If the patient is suffering from non-small cell carcinoma, doctors can only choose to use a regimen with an effective rate of less than 10%, and the patient will also suffer serious adverse reactions. Research. Do a good job of clinical response data at all times, make a more accurate diagnosis for patients, and then combine it with clinical performance. Formulate a specific and precise treatment plan, and conduct evaluation and familiar analysis at all times. Precisely adjusting the treatment plan can control the disease according to the patient or alleviate the adverse clinical manifestations, and avoid adverse drug reactions.

It is globally recognized and unquestionable that precision medical technology brings about a revolution in medicine.

In this area of ​​research, we have invested more than four billion dollars in research funds in four years, and as a result, all the clinical data collected by the future hospital in these five years. Receive human health data from all machine stewards around the world, and establish the world's largest human health data center to conduct research.

And here, I need to thank all the machine stewards and all medical institutions around the world for authorizing the data collection work of the machine stewards, which has brought great help to our research.

In the past four years, our biomedical company has not produced any drugs, and only a few sets of practical auxiliary medical testing equipment have been sold in the global medical field.

It's not that we haven't been able to produce and develop those ordinary drugs, for those drugs that have a cure rate of more than 95 percent. These are not our goals.

In the future, the research goals of biomedical technology companies are all on those drugs with a cure rate of no more than 60%.

Because these fields are all hot medical problems in the world. These include medical problems such as rheumatism and stroke, plus diseases such as cancer and AIDS, combined with big data on human health problems, and through the study of microbial genes, the most effective human treatment for difficult diseases in the field of biomedicine has been obtained so far. Practical treatment and detection techniques.

I am afraid that not many people know that there are two genomes in the human body, one is the gene inherited from parents. There are no more than 25,000 genes, which are the elite before the baby is born. There is another group of genes that enter the human body after birth, especially the more than a thousand symbiotic microorganisms in the human gut. The sum of its genetic information is called the microbiome, also known as the metagenome, which contains more than one million genomes, and the health of the human body can only be guaranteed when these two genomes are coordinated with each other.

In fact, all diseases in the human body can be found in the metagenome at the early stage or even before their symptoms. "

Having said that, Cai Ruichen paused for a moment, and looked at the huge science and technology venue, all was silent, and all pairs of serious eyes were fixed on him.

He continued slowly: "As we all know, the human body health scan owned by the machine housekeeper can detect the information of human diseases in a timely manner, and its accuracy rate has reached 99.5%. Today I will focus on announcing the new key technologies of future biomedical technology in the past four years.

The first technology is the human body safety technology. This technology will also be realized in the machine butler. The new and upgraded version of the machine butler will have the ability to detect cancer cells. After a year of testing, the detection accuracy can be determined to be 100% hundred percent.

This detection ability is able to accurately detect the signs of cell canceration before cancer cells appear in the human body, ensuring that the human body can be discovered and curbed before cancer cells actually appear.

For the specific details, Mr. Lin Zhongxian will give you a detailed introduction at the next machine butler new product launch conference.

Today, as the first scientific and technological product launch conference of future biomedical technology, we will announce to the world that complete cancer data will be available, and the probability of treatment will exceed 95%. "

When Cai Ruichen finally said these words, the entire venue was suddenly in an uproar. At present, all countries and biomedical companies in the world do not have the means to completely cure cancer.

The United States, which has the most advanced medical care, can reduce the mortality rate by 20% at most, and at the same time extend the treatment time by five years.

Cancer of red blood cells is still one of the biggest problems plaguing human health.

Originally, everyone thought it was just a technology show, but the result exceeded everyone's expectations.

In the venue, a white-haired white-haired scholar sitting in the front row excitedly stood up and asked Cai Ruichen, "Dr. Cai, can you tell me about the principle of treatment?"

At this moment, everyone in the venue, including all the cameras of the reporters, all focused on this scholar, and turned their attention to Cai Ruichen, hoping that Cai Ruichen could answer.

The cure rate of the drug for treating cancer is as high as 95%, which will be the biggest medical breakthrough of mankind in the 21st century, none of them. (To be continued.)